NR 565 FINAL EXAM 2026, ADVANCED PHARMACOLOGY
FUNDAMENTALS
,NR 565 Advanced Pharmacology Fundamentals
Final Exam 2026/2027
Complete Study Guide with Answers & Rationales
📋 EXAM INFORMATION
Detail Information
Course NR 565 Advanced Pharmacology Fundamentals
Total Questions 100 Questions
Format Multiple Choice, Select All That Apply, Dosage Calculation
Answers ( ticked )
Time 3 Hours
Passing Score 76% or higher
📚 SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Questions 1–20
Question 1.
A nurse practitioner student is studying drug absorption. Which of the following factors would MOST
significantly increase the rate of drug absorption from the gastrointestinal (GI) tract?
A. High molecular weight of the drug
B. Enteric coating on the tablet
C. Increased GI motility
D. Increased blood flow to the GI tract ✅
Rationale: Increased blood flow to the GI tract enhances drug absorption by maintaining a concentration
gradient. High molecular weight decreases absorption. Enteric coating delays absorption. Increased GI
motility may actually decrease absorption by moving the drug through the gut before it can be
absorbed.
Question 2.
,A patient takes a medication that has a half-life of 8 hours. Approximately how long will it take for the
drug to reach a steady-state concentration?
A. 8 hours
B. 24 hours
C. 40 hours ✅
D. 64 hours
Rationale: Steady state is reached in approximately 4–5 half-lives. With an 8-hour half-life: 5 × 8 = 40
hours. This is a fundamental pharmacokinetic principle tested on NP board exams.
Question 3.
Which of the following best describes the concept of "first-pass effect"?
A. Drug is eliminated primarily by the kidneys
B. Drug binds to plasma proteins upon absorption
C. Drug is metabolized by the liver before reaching systemic circulation ✅
D. Drug reaches peak concentration after the first dose
Rationale: The first-pass effect (first-pass metabolism) refers to hepatic metabolism of a drug before it
reaches systemic circulation. This significantly reduces bioavailability of orally administered drugs such
as morphine and nitroglycerin.
Question 4.
A patient with severe liver disease is prescribed a medication that undergoes extensive hepatic
metabolism. The NP should anticipate:
A. Decreased drug effect due to rapid elimination
B. No change in drug metabolism
C. Increased renal clearance to compensate
D. Increased drug levels and potential toxicity ✅
, Rationale: In hepatic disease, the liver's ability to metabolize drugs is reduced. This results in higher drug
plasma levels, prolonged drug action, and increased risk of toxicity. Dose reductions are typically
required.
Question 5.
Which cytochrome P450 enzyme is responsible for metabolizing the LARGEST number of drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4 ✅
Rationale: CYP3A4 is responsible for metabolizing approximately 50% of all drugs. It is the most
abundant CYP enzyme in the liver and intestine. Drug-drug interactions involving CYP3A4 are clinically
significant and commonly tested.
Question 6.
A patient is taking warfarin and begins taking rifampin for tuberculosis. The NP should expect:
A. Increased anticoagulation effect of warfarin
B. No significant interaction between these drugs
C. Decreased anticoagulation effect of warfarin ✅
D. Rifampin levels to decrease significantly
Rationale: Rifampin is a potent CYP enzyme inducer (CYP3A4, CYP2C9). It increases metabolism of
warfarin, resulting in decreased warfarin levels and reduced anticoagulation effect. Monitoring of INR
and dose adjustment is required.
Question 7.
The term "bioavailability" is defined as:
A. The rate at which a drug is eliminated from the body
B. The total volume in which a drug is distributed in the body
FUNDAMENTALS
,NR 565 Advanced Pharmacology Fundamentals
Final Exam 2026/2027
Complete Study Guide with Answers & Rationales
📋 EXAM INFORMATION
Detail Information
Course NR 565 Advanced Pharmacology Fundamentals
Total Questions 100 Questions
Format Multiple Choice, Select All That Apply, Dosage Calculation
Answers ( ticked )
Time 3 Hours
Passing Score 76% or higher
📚 SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
Questions 1–20
Question 1.
A nurse practitioner student is studying drug absorption. Which of the following factors would MOST
significantly increase the rate of drug absorption from the gastrointestinal (GI) tract?
A. High molecular weight of the drug
B. Enteric coating on the tablet
C. Increased GI motility
D. Increased blood flow to the GI tract ✅
Rationale: Increased blood flow to the GI tract enhances drug absorption by maintaining a concentration
gradient. High molecular weight decreases absorption. Enteric coating delays absorption. Increased GI
motility may actually decrease absorption by moving the drug through the gut before it can be
absorbed.
Question 2.
,A patient takes a medication that has a half-life of 8 hours. Approximately how long will it take for the
drug to reach a steady-state concentration?
A. 8 hours
B. 24 hours
C. 40 hours ✅
D. 64 hours
Rationale: Steady state is reached in approximately 4–5 half-lives. With an 8-hour half-life: 5 × 8 = 40
hours. This is a fundamental pharmacokinetic principle tested on NP board exams.
Question 3.
Which of the following best describes the concept of "first-pass effect"?
A. Drug is eliminated primarily by the kidneys
B. Drug binds to plasma proteins upon absorption
C. Drug is metabolized by the liver before reaching systemic circulation ✅
D. Drug reaches peak concentration after the first dose
Rationale: The first-pass effect (first-pass metabolism) refers to hepatic metabolism of a drug before it
reaches systemic circulation. This significantly reduces bioavailability of orally administered drugs such
as morphine and nitroglycerin.
Question 4.
A patient with severe liver disease is prescribed a medication that undergoes extensive hepatic
metabolism. The NP should anticipate:
A. Decreased drug effect due to rapid elimination
B. No change in drug metabolism
C. Increased renal clearance to compensate
D. Increased drug levels and potential toxicity ✅
, Rationale: In hepatic disease, the liver's ability to metabolize drugs is reduced. This results in higher drug
plasma levels, prolonged drug action, and increased risk of toxicity. Dose reductions are typically
required.
Question 5.
Which cytochrome P450 enzyme is responsible for metabolizing the LARGEST number of drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4 ✅
Rationale: CYP3A4 is responsible for metabolizing approximately 50% of all drugs. It is the most
abundant CYP enzyme in the liver and intestine. Drug-drug interactions involving CYP3A4 are clinically
significant and commonly tested.
Question 6.
A patient is taking warfarin and begins taking rifampin for tuberculosis. The NP should expect:
A. Increased anticoagulation effect of warfarin
B. No significant interaction between these drugs
C. Decreased anticoagulation effect of warfarin ✅
D. Rifampin levels to decrease significantly
Rationale: Rifampin is a potent CYP enzyme inducer (CYP3A4, CYP2C9). It increases metabolism of
warfarin, resulting in decreased warfarin levels and reduced anticoagulation effect. Monitoring of INR
and dose adjustment is required.
Question 7.
The term "bioavailability" is defined as:
A. The rate at which a drug is eliminated from the body
B. The total volume in which a drug is distributed in the body
